Results 11 to 20 of about 1,643 (166)

Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration [PDF]

open access: yesHaematologica
Histiocytic neoplasms are rare hematologic disorders characterized by pathological infiltration of myeloid-derived cells in various organs, resulting in diverse manifestations.
Oshrat Hershkovitz-Rokah   +3 more
doaj   +2 more sources

Indeterminate Cell Histiocytosis: Report of a Case

open access: greenActa Medica Iranica, 2014
Indeterminate cell histiocytosis is a very rare disorder of histiocytes proliferation. It has both Langerhans and non-Langerhans cell histiocytosis immunophenotypic features.
Alireza Ghanadan   +8 more
doaj   +1 more source

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features. [PDF]

open access: yesBlood Adv
Non-Langerhans cell histiocytoses are a diverse group of histiocytic diseases. Different entities are defined based on clinical, histopathologic, and/or molecular characteristics. This study aimed to define NTRK-rearranged histiocytosis.
Fragneau R   +34 more
europepmc   +3 more sources

Indeterminate Cell Histiocytosis Presenting with Leonine Facies

open access: goldActa Dermato-Venereologica, 2018
Cheng Chen   +2 more
doaj   +3 more sources

WHO classification of skin tumours: key updates in the fifth edition. [PDF]

open access: yesHistopathology
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Goldman-Lévy G   +29 more
europepmc   +2 more sources

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts. [PDF]

open access: yesAm J Hematol
ABSTRACT Although all myeloid cells are considered to derive from hematopoietic stem cells, the cells in each myeloid lineage are heterogeneous populations, and their distribution and functions vary, depending on underlying physiologic and pathologic processes, age, sex, and genetic and epigenetic signatures.
Valent P   +27 more
europepmc   +2 more sources

Indeterminate dendritic cell tumor (IDCT) [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2023
Indeterminate dendritic cell tumor (IDCT) is rare histiocytic tumor characterized by the proliferation of indeterminate dendritic cells. It is more often diagnosed in middle-aged people, in approximately equal proportions in men and women.
Evgenia V. Okladnikova   +4 more
doaj   +1 more source

Assessment of Hemophagocytic Lympho-Histiocytosis (HLH) in the Setting of Adult Acute Liver Failure. [PDF]

open access: yesJ Viral Hepat
ABSTRACT Hemophagocytic lympho‐histiocytosis (HLH) is a life‐threatening disease, only occasionally presenting as acute liver failure (ALF) in adults. HLH is challenging to diagnose. We reviewed the ALF Study Group (ALFSG) registry for suspected HLH subjects, as well as 184 with other ALF etiologies for cases that might have been missed, assessing ...
Anouti A   +5 more
europepmc   +2 more sources

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Non-Langerhans cell histiocytosis, including Erdheim–Chester disease (ECD), Rosai–Dorfman disease (RDD), indeterminate cell histiocytosis (ICH), and unclassified histiocytosis, is a rare disorder lacking a standard treatment strategy.
Ting Liu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy